US Senator has come out against the appointment of Dr. Scott Gottlieb as the next commissioner of the Food and Drug Administration over concerns he is not sufficiently tough on thwarting the inappropriate use of opioid painkillers. And the move appears to be the first official opposition from a lawmaker to the nomination.

In a blunt statement Wednesday, Senator Ed Markey (D-Mass.) accused Gottlieb, a former FDA official, of failing to support the use of the various approaches the FDA can take to “minimize the risks to public health from the misuse of prescription opioids.”

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Sign up for our
Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine — delivered straight to your inbox every weekday afternoon.

Recommended Stories